Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Entero Healthcare SolutionsNSE:ENTERO +2.55%44 PEG Ratio is 0.58 as of Jul. 14, 2026, which is 2% above its 10-year median of 0.57. GuruFocus rates NSE:ENTERO with a GF Score™ of 44/100. The stock has 2 warning signs investors should review. Among 48 Medical Distribution companies, Entero Healthcare Solutions ranks better than 79.17% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Entero Healthcare Solutions's PEG Ratio or its related term are showing as below:
NSE:ENTERO'
s PEG Ratio Range Over the Past 10 Years
Min: 0.51 Med: 0.57 Max: 0.64
Current: 0.58
During the past 6 years, Entero Healthcare Solutions's highest PEG Ratio was 0.64. The lowest was 0.51. And the median was 0.57.
NSE:ENTERO's PEG Ratio is ranked better than 79.17% of 48
companies
in the Medical Distribution industry
Industry Median: 1.91
vs NSE:ENTERO: 0.58
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Entero Healthcare Solutions (NSE:ENTERO) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Entero Healthcare Solutions PEG Ratio Related Terms
Entero Healthcare Solutions PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Entero Healthcare Solutions's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions PEG Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Entero Healthcare Solutions (NSE:ENTERO) has a PEG Ratio of 0.58 as of Jul. 14, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Entero Healthcare Solutions and its competitors. This is near median its historical median of 0.57. Over the past decade, Entero Healthcare Solutions' PEG Ratio has ranged from 0.51 to 0.64. According to the industry distribution chart, Entero Healthcare Solutions ranks #10 out of 48 companies in the Medical Distribution industry, placing it in the top 20.8%.
Is Entero Healthcare Solutions' PEG Ratio too high?
Entero Healthcare Solutions' current PEG Ratio of 0.58 is near median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 0.64. The Medical Distribution industry median PEG Ratio is 1.91. Entero Healthcare Solutions' value of 0.58 is 69.6% below this industry median. Based on the distribution chart, Entero Healthcare Solutions ranks #10 out of 48 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Entero Healthcare Solutions has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' PEG Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #10 out of 48 companies for PEG Ratio. This places Entero Healthcare Solutions in the top 21% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.91. Entero Healthcare Solutions' value of 0.58 is 69.6% below this benchmark. Historically, Entero Healthcare Solutions' own PEG Ratio has ranged from 0.51 to 0.64 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 1.91, Entero Healthcare Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Distribution company?
The median PEG Ratio among Medical Distribution companies is 1.91, based on 48 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current PEG Ratio of 0.58 is 69.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Entero Healthcare Solutions and its competitors. For the Medical Distribution industry, the median PEG Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current PEG Ratio is 0.58, which is near median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current PEG Ratio of 0.58. The current PEG Ratio is 0.58, which is near median its 10-year median of 0.57 and 69.6% below the Medical Distribution industry median of 1.91. Entero Healthcare Solutions' overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current PEG Ratio is 0.58 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
44GF Score
Get the complete analysis for NSE:ENTERO
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ENTERO has been successfully added to your 
